Literature DB >> 34907483

Strategies for Liposome Drug Delivery Systems to Improve Tumor Treatment Efficacy.

Jia Wang1, Junbo Gong1, Zhenping Wei2.   

Abstract

In the advancement of tumor therapy, in addition to the search for new antitumor compounds, the development of nano-drug delivery systems has opened up new pathways for tumor treatment by addressing some of the limitations of traditional drugs. Liposomes have received much attention for their high biocompatibility, low toxicity, high inclusivity, and improved drug bioavailability. They are one of the most studied nanocarriers, changing the size and surface characteristics of liposomes to better fit the tumor environment by taking advantage of the unique pathophysiology of tumors. They can also be designed as tumor targeting drug delivery vehicles for the precise delivery of active drugs into tumor cells. This paper reviews the current development of liposome formulations, summarizes the characterization methods of liposomes, and proposes strategies to improve the effectiveness of tumor treatment. Finally, it provides an outlook on the challenges and future directions of the field. Graphical abstract.
© 2021. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.

Entities:  

Keywords:  liposome characterization; liposomes; targeted drug delivery; tumor targeting; tumor therapy

Mesh:

Substances:

Year:  2021        PMID: 34907483     DOI: 10.1208/s12249-021-02179-4

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  73 in total

Review 1.  Liposomes: from the bench to the bed.

Authors:  Daan J A Crommelin; Gert Storm
Journal:  J Liposome Res       Date:  2003-02       Impact factor: 3.648

Review 2.  Design of liposomes as drug delivery system for therapeutic applications.

Authors:  Diana Guimarães; Artur Cavaco-Paulo; Eugénia Nogueira
Journal:  Int J Pharm       Date:  2021-04-02       Impact factor: 5.875

3.  Practical aspects in size and morphology characterization of drug-loaded nano-liposomes.

Authors:  Sivan Peretz Damari; Dima Shamrakov; Maxim Varenik; Erez Koren; Einat Nativ-Roth; Yechezkel Barenholz; Oren Regev
Journal:  Int J Pharm       Date:  2018-06-18       Impact factor: 5.875

4.  Influence of cholesterol on liposome stability and on in vitro drug release.

Authors:  Maria-Lucia Briuglia; Chiara Rotella; Amber McFarlane; Dimitrios A Lamprou
Journal:  Drug Deliv Transl Res       Date:  2015-06       Impact factor: 4.617

5.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

6.  Theranostics Based on Liposome: Looking Back and Forward.

Authors:  Wooseung Lee; Hyung-Jun Im
Journal:  Nucl Med Mol Imaging       Date:  2019-07-22

7.  Updates on the use of liposomes for active tumor targeting in cancer therapy.

Authors:  Wei Yan; Sharon Sy Leung; Kenneth Kw To
Journal:  Nanomedicine (Lond)       Date:  2019-12-05       Impact factor: 5.307

8.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

Review 9.  Tumor-targeted nanomedicines for cancer theranostics.

Authors:  Alexandra G Arranja; Vertika Pathak; Twan Lammers; Yang Shi
Journal:  Pharmacol Res       Date:  2016-11-16       Impact factor: 7.658

Review 10.  Liposomes as nanomedical devices.

Authors:  Giuseppina Bozzuto; Agnese Molinari
Journal:  Int J Nanomedicine       Date:  2015-02-02
View more
  4 in total

Review 1.  Advances in Nanoliposomes for the Diagnosis and Treatment of Liver Cancer.

Authors:  Yitong Li; Ruihang Zhang; Zhen Xu; Zhicheng Wang
Journal:  Int J Nanomedicine       Date:  2022-02-26

2.  Liposome-based nanocapsules for the controlled release of dietary curcumin: PDDA and silica nanoparticle-coated DMPC liposomes enhance the fluorescence efficiency and anticancer activity of curcumin.

Authors:  Alaa K Othman; Riham El Kurdi; Adnan Badran; Joelle Mesmar; Elias Baydoun; Digambara Patra
Journal:  RSC Adv       Date:  2022-04-11       Impact factor: 3.361

Review 3.  Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy.

Authors:  Ruogang Zhao; Jianhao Liu; Zhaohuan Li; Wenhui Zhang; Feng Wang; Bo Zhang
Journal:  Pharmaceutics       Date:  2022-07-25       Impact factor: 6.525

Review 4.  Peptides to Overcome the Limitations of Current Anticancer and Antimicrobial Nanotherapies.

Authors:  Valentina Del Genio; Rosa Bellavita; Annarita Falanga; Katel Hervé-Aubert; Igor Chourpa; Stefania Galdiero
Journal:  Pharmaceutics       Date:  2022-06-10       Impact factor: 6.525

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.